Healthcare -
Biotechnology - NASDAQ - US
$ 19.935
-0.722 %
$ 1.58 B
Market Cap
-4.61
P/E
VRDN - COMMON STOCK
Common Stock VRDN - Viridian Therapeutics, Inc.
540 K
LAST VALUE
50.31%
2 YEAR CAGR
11.88%
5 YEAR CAGR
34.48%
10 YEAR CAGR